Side A · Liner notes
STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down
Nutrition · Words by Elaine Chen · Released
Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is resurrecting its lead program:
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. Read on to find out what my colleague was doing in Pennsylvania Dutch country and what the latest dispute between Novo and Lilly is all about.
A Mennonite community is set on solving one of biotech’s most vexing problems
In Pennsylvania Dutch country, one doctor has long been working with biotech companies and academics to develop gene therapies for the sickest children in local Amish and Mennonite communities.
